title: Platelet amyloid precursor protein isoform expression in Alzheimer's disease: evidence for peripheral marker.
abstract: Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by a progressive cognitive and memory decline. Among peripheral markers of AD, great interest has been focused on the amyloid precursor protein (APP). In this regard, platelets represent an important peripheral source of APP since it has been demonstrated that the three major isoforms, that are constituted of 770, 751 and 695 aa residues, are inserted in the membrane of resting platelets. APP 751 and APP 770 contain a Kunitz-type serine protease inhibitor domain (APP KPI) and APP 695 lacks this domain. To address this issue, we first examined the platelet APP isoform mRNAs prospectively as biomarker for the diagnosis of AD by means of real-time quantitative PCR, and then evaluated the correlation between APP mRNA expression levels and cognitive impairment of enrolled subjects. Differential gene expression measurements in the AD patient group (n=18) revealed a significant up-regulation of APP TOT (1.52-fold), APP KPI (1.32-fold), APP 770 (1.33-fold) and APP 751 (1.26-fold) compared to controls (n=22). Moreover, a statistically significant positive correlation was found between APP mRNA levels (TOT, KPI, 770 and 751) and cognitive impairment. Since AD definitive diagnosis still relies on pathological evaluation at autopsy, the present results are consistent with the hypothesis that platelet APP could be considered a potential reliable peripheral marker for studying AD and could contribute to define a signature for the presence of AD pathology.
authors.forename: A
authors.initials: A
authors.lastname: Vignini
authors.forename: D
authors.initials: D
authors.lastname: Sartini
authors.forename: S
authors.initials: S
authors.lastname: Morganti
authors.forename: L
authors.initials: L
authors.lastname: Nanetti
authors.forename: S
authors.initials: S
authors.lastname: Luzzi
authors.forename: L
authors.initials: L
authors.lastname: Provinciali
authors.forename: L
authors.initials: L
authors.lastname: Mazzanti
authors.forename: M
authors.initials: M
authors.lastname: Emanuelli
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000097:blood / Q000235:genetics* / Q000503:physiopathology; D016564:Amyloid beta-Protein Precursor / Q000235:genetics*; D015415:Biomarkers / Q000097:blood; D001792:Blood Platelets / Q000737:chemistry*; D016022:Case-Control Studies; D003071:Cognition; D005260:Female; D006801:Humans; D007558:Italy; D008297:Male; D016133:Polymerase Chain Reaction; D011446:Prospective Studies; D012333:RNA, Messenger / Q000097:blood; D015854:Up-Regulation
chemical_list: C545487:APP protein, human; D016564:Amyloid beta-Protein Precursor; D015415:Biomarkers; D012333:RNA, Messenger